Equipoise for Laminoplasty Versus Fusion for Cervical Spondylotic Myelopathy: Is a Randomized Trial Feasible?

BACKGROUND AND OBJECTIVES: There is global variation and uncertainty regarding the utilization of laminoplasty in the treatment of patients with degenerative cervical spondylotic myelopathy. We asked whether clinical equipoise can be established among cervical spine surgeon experts for a possible trial comparing laminoplasty with fusion. METHODS: Fifty randomly selected cases from a cervical spondylotic myelopathy trial [NCT-02076113] were presented to 26 cervical spine experts to determine the suitability of randomization to laminoplasty vs fusion surgery. A brief clinical vignette, sagittal T2-weighted MRI, and appropriate axial images were reviewed by the experts. Each expert assessed the randomizability of each case and then stated the choice of approach: laminoplasty, fusion (anterior or posterior), arthroplasty, or no surgery. After 6 months, the same 50 cases were reviewed by all experts. RESULTS: Among 50 cases, 46 (92%) were deemed suitable for randomization by a simple majority at both time points. The response rate of the expert panel members was 100% at both time points. Among 2600 surgeon responses over 2 time points, experts stated their choice of approach as laminoplasty in 40% of instances and selected fusion (anterior or posterior) in 57% of cases. Temporal stability of decision-making was high with mean stability = 0.85 (SD = 0.09), indicating that surgeons generally maintained similar treatment decisions over 6 months. A subset (12 experts) of the expert panel who reviewed these 50 cases over 10 years ago demonstrated a significant increase in the preference for laminoplasty from 18% to 40% ( P < .001). CONCLUSION: Among cervical spine experts, laminoplasty utilization has increased over 10 years. Global cervical spine experts demonstrate equipoise for comparing laminoplasty with fusion. The results suggest that a significant proportion of patients with cervical myelopathy would be eligible for a future trial and the results would be likely to affect global practice.

Authors

Institutions

Publication Details

Journal
Neurosurgery Open
Published
2026-11-12
DOI
https://doi.org/10.1227/neuprac.0000000000000326
Primary Topic
Cervical and Thoracic Myelopathy
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Equipoise for Laminoplasty Versus Fusion for Cervical Spondylotic Myelopathy: Is a Randomized Trial Feasible?

Subu N. Magge, Adam S. Kanter, Todd James Albert, Langston Tyler Holly et al.
Neurosurgery Open
Cervical and Thoracic Myelopathy
article

Equipoise for Laminoplasty Versus Fusion for Cervical Spondylotic Myelopathy: Is a Randomized Trial Feasible?

Subu N. Magge, Adam S. Kanter, Todd James Albert, Langston Tyler Holly, Vedantam Rajshekhar, Michael P. Steinmetz, Praveen V. Mummaneni, Marjorie Wang, Andrés Combalía, John M. Rhee, Robert G. Whitmore, Christopher I. Shaffrey, Ryan D. Adkins, James Shields Harrop, Michael George Fehlings, Tasneem Zaihra, Daniel J. Hoh, Steve C. Ludwig, Luis M. Tumialán, Tom E. Mroz, Carmen L. A. Vleggeert-Lankamp, Zoher Ghogawala, Kiehyun Daniel Riew, Lucy Xiaolu Wang, Asdrúbal Falavigna, Brandon Douglas Lawrence, Paul M. Arnold, Wilson Zack Ray, Daniel K. Resnick, John G. Heller, Vincent C. Traynelis, A. S. Patel, Mohamad Bydon, Madison E. Liesching, Michael Y. Wang, Dean Chou
article en

Abstract

BACKGROUND AND OBJECTIVES: There is global variation and uncertainty regarding the utilization of laminoplasty in the treatment of patients with degenerative cervical spondylotic myelopathy. We asked whether clinical equipoise can be established among cervical spine surgeon experts for a possible trial comparing laminoplasty with fusion. METHODS: Fifty randomly selected cases from a cervical spondylotic myelopathy trial [NCT-02076113] were presented to 26 cervical spine experts to determine the suitability of randomization to laminoplasty vs fusion surgery. A brief clinical vignette, sagittal T2-weighted MRI, and appropriate axial images were reviewed by the experts. Each expert assessed the randomizability of each case and then stated the choice of approach: laminoplasty, fusion (anterior or posterior), arthroplasty, or no surgery. After 6 months, the same 50 cases were reviewed by all experts. RESULTS: Among 50 cases, 46 (92%) were deemed suitable for randomization by a simple majority at both time points. The response rate of the expert panel members was 100% at both time points. Among 2600 surgeon responses over 2 time points, experts stated their choice of approach as laminoplasty in 40% of instances and selected fusion (anterior or posterior) in 57% of cases. Temporal stability of decision-making was high with mean stability = 0.85 (SD = 0.09), indicating that surgeons generally maintained similar treatment decisions over 6 months. A subset (12 experts) of the expert panel who reviewed these 50 cases over 10 years ago demonstrated a significant increase in the preference for laminoplasty from 18% to 40% ( P < .001). CONCLUSION: Among cervical spine experts, laminoplasty utilization has increased over 10 years. Global cervical spine experts demonstrate equipoise for comparing laminoplasty with fusion. The results suggest that a significant proportion of patients with cervical myelopathy would be eligible for a future trial and the results would be likely to affect global practice.

Neurosurgery OpenVol. 7(6)
Northwestern University (US), Leiden University (NL), University of Maryland, Baltimore (US), Hospital for Special Surgery (US), Lahey Hospital and Medical Center (US), Hoag Memorial Hospital Presbyterian (US), Barrow Neurological Institute (US), University Health Network (CA), University of Wisconsin–Madison (US), University of Miami (US), Thomas Jefferson University (US), Emory University (US), University of California, Los Angeles (US), Duke University (US), Christian Medical College, Vellore (IN), University of California, San Francisco (US), University of Toronto (CA), Loyola University Chicago (US), Medical College of Wisconsin (US), Washington University in St. Louis (US), University of Applied Sciences Leiden (NL), University of Utah (US), University of Massachusetts Amherst (US), University of Florida Health (US), Universidade de Caxias do Sul (BR), University of Florida (US), Cleveland Clinic Lerner College of Medicine (US), University of Chicago (US), Lahey Medical Center (US), Duke Medical Center (US), Max Planck Institute for Innovation and Competition (DE), Barrow Brain and Spine (US), Northwestern Medicine (US), Weill Cornell Medicine (US), Rush University (US), University of Cincinnati (US), Universitat de Barcelona (ES)
Good health and well-being
Cervical and Thoracic Myelopathy
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon